Trophoblast cell preparations
Patent Number: 6630349
Date of First Priority Issue: Wednesday September 23rd, 1998
Date Issued: Sunday September 7th, 2003
Assignee: Mount Sinai Hospital (Toronto, CA)
Inventors: Rossant, Janet (Toronto, CA); Tanaka, Satoshi (Tokyo, JP); Kunath, Tilo (Toronto, CA)
From Class: Type
Comments: No comments
This patent provides trophoblast cell lines that are of murine origin. Since the trophoblast is similar to cancer cells in terms of immune suppression and metastizing ability, this patent is useful for the generation of a xenogeneic cancer vaccine, similar to XenoVax. The fact that trophoblast stem cells are provided is useful since this can be a good off the shelf starting population for generation of XenoVax.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.